270 related articles for article (PubMed ID: 10419604)
1. Denaturation of type II collagen in articular cartilage in experimental murine arthritis. Evidence for collagen degradation in both reversible and irreversible cartilage damage.
Stoop R; van der Kraan PM; Buma P; Hollander AP; Poole AR; van den Berg WB
J Pathol; 1999 Jul; 188(3):329-37. PubMed ID: 10419604
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis.
van Meurs JB; van Lent PL; Holthuysen AE; Singer II; Bayne EK; van den Berg WB
Arthritis Rheum; 1999 Jun; 42(6):1128-39. PubMed ID: 10366105
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
4. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis.
Kojima T; Mwale F; Yasuda T; Girard C; Poole AR; Laverty S
Arthritis Rheum; 2001 Jan; 44(1):120-7. PubMed ID: 11212149
[TBL] [Abstract][Full Text] [Related]
5. Type II collagen degradation in spontaneous osteoarthritis in C57Bl/6 and BALB/c mice.
Stoop R; van der Kraan PM; Buma P; Hollander AP; Billinghurst RC; Poole AR; van den Berg WB
Arthritis Rheum; 1999 Nov; 42(11):2381-9. PubMed ID: 10555034
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
[TBL] [Abstract][Full Text] [Related]
7. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
8. Differences in type II collagen degradation between peripheral and central cartilage of rat stifle joints after cranial cruciate ligament transection.
Stoop R; Buma P; van der Kraan PM; Hollander AP; Clark Billinghurst R; Robin Poole A; van den Berg WB
Arthritis Rheum; 2000 Sep; 43(9):2121-31. PubMed ID: 11014364
[TBL] [Abstract][Full Text] [Related]
9. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
[TBL] [Abstract][Full Text] [Related]
10. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
11. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
Singer II; Kawka DW; Bayne EK; Donatelli SA; Weidner JR; Williams HR; Ayala JM; Mumford RA; Lark MW; Glant TT
J Clin Invest; 1995 May; 95(5):2178-86. PubMed ID: 7537757
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1.
Dodge GR; Poole AR
J Clin Invest; 1989 Feb; 83(2):647-61. PubMed ID: 2783591
[TBL] [Abstract][Full Text] [Related]
13. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
Ishikawa T; Nishigaki F; Christgau S; Noto T; Mo J; From N; Minoura K; Hirayama Y; Ohkubo Y; Mutoh S
J Rheumatol; 2004 Jun; 31(6):1174-9. PubMed ID: 15170932
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
van de Loo FA; Kuiper S; van Enckevort FH; Arntz OJ; van den Berg WB
Am J Pathol; 1997 Jul; 151(1):177-91. PubMed ID: 9212744
[TBL] [Abstract][Full Text] [Related]
15. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR
Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
[TBL] [Abstract][Full Text] [Related]
16. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
18. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
19. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
20. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
